Effects of S-nitroso-glutathione in the human forearm circulation: evidence for selective inhibition of platelet activation

1994 ◽  
Vol 28 (5) ◽  
pp. 691-694 ◽  
Author(s):  
A. J d. Belder ◽  
R. MacAllister ◽  
M. W Radomski ◽  
S. Moncada ◽  
P. J T Vallance
2003 ◽  
Vol 89 (03) ◽  
pp. 438-445 ◽  
Author(s):  
Jacobus Burggraaf ◽  
Rik Schoemaker ◽  
Adam Cohen ◽  
Cornelis Kluft ◽  
Stanley Chia ◽  
...  

SummaryNineteen healthy men received unilateral brachial artery infusions of either unfractioned heparin (0.3-100 IU/min), saline or the endothelium-dependent vasodilators substance P (2-8 pmol/min) and bradykinin (100-1000 pmol/min), and the endothelium-independent vasodilator sodium nitroprusside (2-8 µg/min). Heparin caused a dose-dependent increase in plasma TFPI concentrations in both arms (ANOVA, p <0.0001). Estimated net forearm TFPI release was 7 ± 16, 29 ± 20 and 138 ± 72 ng/100 mL tissue/min during 10, 30 and 100 IU/min of heparin respectively (ANOVA, p <0.0001). Compared to the systemic circulation, the forearm sensitivity to heparin induced TFPI release was 3.6-fold lower (166 ± 67 ng/IU vs. 596 ± 252 ng/IU: t-test, p = 0.004). Substance P, bradykinin and sodium nitroprusside all caused substantial dose-dependent increases in blood flow (ANOVA, p <0.001 for all) without affecting plasma TFPI concentrations. There are important regional differences in endothelial TFPI release, with the forearm circulation being relatively insensitive to heparin.


1997 ◽  
Vol 159 (2) ◽  
pp. 107-111 ◽  
Author(s):  
T. KAHAN ◽  
M. LINDQVIST ◽  
J. NUSSBERGER ◽  
A. MELCHER ◽  
P. HJEMDAHL

2006 ◽  
Vol 41 (2) ◽  
pp. 295-301 ◽  
Author(s):  
Tienush Rassaf ◽  
Christian Heiss ◽  
Ulrike Hendgen-Cotta ◽  
Jan Balzer ◽  
Simone Matern ◽  
...  

Blood ◽  
2007 ◽  
Vol 110 (5) ◽  
pp. 1475-1482 ◽  
Author(s):  
Wei Zhang ◽  
Robert W. Colman

Abstract Thrombin-induced cyclic AMP (cAMP) reduction potentates several steps in platelet activation, including Ca++ mobilization, cytoskeletal reorganization, and fibrinogen receptor conformation. We now reinvestigate the signaling pathways by which intracellular cAMP content is controlled after platelet activation by thrombin. When washed human platelets were stimulated with thrombin, cAMP-dependent phosphodiesterase (PDE3A) activity was significantly increased. A nonselective PDE inhibitor, 3-isobutyl-1-methylxanthine (IBMX), and the PDE3 selective inhibitors milrinone and cilostazol each suppressed thrombin-induced cAMP-dependent PDE responses, but not 2 different PDE2 inhibitors. Selective inhibition of PDE3A resulted in reversal of thrombin-induced cAMP reduction, indicating that thrombin activated PDE3A. In synergy with inhibition of adenylate cyclase by thrombin, activated PDE3A accelerates cAMP hydrolysis and maximally reduces the cAMP content. Thrombin-induced PDE3A activation was diminished concomitantly with dephosphorylation of PDE3A by protein phosphatase 1 (PP1). An Akt inhibitor blocked PDE3A activation and constrained thrombin-induced cAMP reduction. A P2Y12 inhibitor also reduced thrombin-induced cAMP reduction. The combination of both reversed cAMP decrease by thrombin. Thrombin-mediated phosphorylated PDE3A was isolated by liquid chromatography, detected by a monoclonal antibody against Akt-phosphorylated substrate, and verified by immunoprecipitation study. The predominant isoform phosphorylated by Akt was the 136-kDa species. We suggest that activation/phosphorylation of PDE3A via Akt signaling pathway participates in regulating cAMP during thrombin activation of platelets.


2004 ◽  
Vol 287 (1) ◽  
pp. H395-H400 ◽  
Author(s):  
Melinda M. Parnell ◽  
Jaye P. F. Chin-Dusting ◽  
Jennifer Starr ◽  
David M. Kaye

Whereas l-arginine is clearly recognized as the precursor for nitric oxide synthesis, and its entry into endothelial cells via system y+ transport is established, few data exist regarding the acute regulation of this transport process. We specifically investigated the effect of ACh and isoprenaline (Iso) on l-arginine uptake in the human forearm and in cultured bovine aortic endothelial cells (BAEC). Sixteen healthy males were studied. During a steady-state intra-arterial infusion of [3H]l-arginine (100 nCi/min), the effects of ACh (9.25 and 37 μg/min), Iso (25–50 and 200 μg/min), and sodium nitroprusside (SNP) (1–2 and 8 μg/min) on forearm plasma flow (FPF), l-[3H]arginine uptake, and l-[3H]citrulline release were determined. In parallel experiments, the effects of ACh, Iso, and SNP on l-[3H]arginine uptake were studied in BAEC. l-Arginine uptake was inversely related to FPF ( r = −0.50; P < 0.005). At a similar FPF (ACh 56.82 ± 9.25, Iso 58.49 ± 5.56, SNP 57.92 ± 4.96 ml/min; P = ns), intra-arterial ACh significantly increased forearm uptake of l-[3H]arginine (54,655 ± 8,018 dpm/min), compared with that observed with either Iso (40,517.23 ± 6,841 dpm/min; P = 0.01) or SNP (36,816 ± 4,650 dpm/min; P = 0.011). This was associated with increased ACh-induced l-[3H]citrulline release compared with Iso and SNP ( P = 0.046). Similarly, in BAEC, ACh significantly increased l-[3H]arginine uptake compared with control, Iso, or SNP (ACh 12.0 × 107 ± 1.83 × 107 vs. control 6.67 × 107 ± 1.16 × 107 vs. Iso 7.35 × 107 ± 1.63 × 107 vs. SNP 6.01 × 107 ± 1.11 × 107 fmol·min−1·mg−1 at 300 μmol/l l-arginine; P = 0.043). Taken together, these data indicate that ACh stimulates l-arginine uptake in cultured endothelial cells and in human forearm circulation, indicating the potential for acute modulation of endothelial l-arginine uptake.


Blood ◽  
2005 ◽  
Vol 106 (11) ◽  
pp. 3731-3731
Author(s):  
Chiara d’Agostino ◽  
Andre Dejam ◽  
Mildred Pelletier ◽  
Nathawut Sibmooh ◽  
Fabiola Rizzatti ◽  
...  

Abstract Our recent studies suggest that nitrite ions serve as a storage pool of nitric oxide (NO•) bioactivity, with reduction of nitrite to NO• within red blood cells (RBC), thus potentially explaining endocrine effects of NO•. We have investigated nitrite uptake and decay in human RBC using recently described methodologies based on assaying after stabilization of nitrite to reaction with hemoglobin by treatment with ferricyanide and quantificating by reductive chemiluminescence. Uptake of nitrite added to whole blood is very rapid (sec) and independent of temperature (from 4°C to 37°C) and state of oxygenation of the cells, or treatment with carbon monoxide. We obtain intracellular values as high as 711 ± 45.44 nM/l with an extracellular value of 10,935.089 ± 897.370 nM/l. Decay of nitrite levels within the RBC is, however, strongly temperature and ligand dependent. At 37°C only 22% of the original maximal value remains at 30 minutes (half life: 5.24 min), while there is no apparent decay at 4°C. Carbon monoxide also prevents nitrite destruction. If the nitrite-containing RBC are suspended in nitrite-free plasma, decay of nitrite levels is faster (half life 2.1min) suggesting export of nitrite as well as reaction with hemoglobin. We have also observed whole blood and RBC artery-to-vein gradients of nitrite levels in human forearm circulation suggesting rapid loss during RBC transit of the microcirculation. These results suggest rapid fluxes of nitrite ions into and out of RBC, as well as controlled intra-erythrocytic metabolism, which could contribute to local, rapid modulation of blood flow by mechanisms involving nitrite activation to NO• by intra-erythrocytic hemoglobin.


Sign in / Sign up

Export Citation Format

Share Document